Abstract:Enhancing neuronal α7 nicotinic acetylcholine receptor (α7 nAChR) function can alleviate cognitive deficits. Here, we report the design, synthesis, and evaluation of N-(4-(trifluoromethoxy)phenyl)-1,3,5-triazin-2-amine derivatives 8–10 as a series of novel α7 nAChR positive allosteric modulators (PAMs). The representative compound 10e functions as a type I PAM with an EC50 of 3.0 μM and approximately 38-fold enhancement of α7 current in the presence of agonist acetylcholine (100 μM). It specifically enhances α7 current with high selectivity. Compound 10e shows good pharmacokinetic property in mice. Intraperitoneal injection of 10e (3 mg/kg) exhibits sufficient blood–brain barrier penetration in mice. Furthermore, 10e can also rescue the auditory gating deficit in mice with schizophrenia-like behavior. Molecular docking of 10e with homopentameric α7 nAChR reveals a new mode of action. These results support the potential of 10e for treatment for schizophrenia and Alzheimer's disease.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c01058.Rat liver microsome stability assessment of test compounds; Individual concentrations of 9d in rats dosed by IV at 1 mg/kg; Individual concentrations of 9d in rats dosed by PO at 10 mg/kg; Individual concentrations of 10d in mice dosed by IV at 1 mg/kg and PO/IP at 3 mg/kg; Individual concentrations of 10e in mice dosed by IV at 1 mg/kg and PO/IP at 3 mg/kg; Selective increase on other subtypes by compound 8l, 9d, and 10e instead of α7 nAChR current; Mean concentrations of 10e in plasma and brain; NMR spectra, HPLC reports and HRMS of the target compounds 8–10 (PDF)PAINS filter using False Positive Remover (PDF)Molecular formula strings of the target compounds (CSV)Docking results of compound 5b with modeled human alpha 7 nAChR (PDB)Docking results of compound 10e with modeled human alpha 7 nAChR (PDB)This article has not yet been cited by other publications.

The Current Agonists and Positive Allosteric Modulators of Α7 Nachr for CNS Indications in Clinical Trials

The current agonists and positive allosteric modulators of α7 nAChR for CNS indications in clinical trials.

α7 Nicotinic receptor modulators for cognitive deficits in schizophrenia and Alzheimer's disease

The α7 nAChR selective agonists as drug candidates for Alzheimer's disease.

Physiologic Functions and Therapeutic Applications of α7 Nicotinic Acetylcholine Receptor in Brain Disorders

Pharmacological Properties and Evaluations of a Novel Positive Allosteric Modulator of Α7 Nachr for Attenuation of Schizophrenia-Like Behavior in Mice

Allosteric Activation of α7 Nicotinic Acetylcholine Receptors by Novel 2-Arylamino-thiazole-5-carboxylic Acid Amide Derivatives for the Improvement of Cognitive Deficits in Mice

Synthesis and Biological Evaluation of Novel Triazine Derivatives as Positive Allosteric Modulators of α7 Nicotinic Acetylcholine Receptors

An Allosteric Modulator of the α7 Nicotinic Acetylcholine Receptor Possessing Cognition-Enhancing Properties in Vivo

Preclinical Characterization Of A-582941: A Novel Alpha 7 Neuronal Nicotinic Receptor Agonist With Broad Spectrum Cognition-Enhancing Properties

Preclinical Characterization of A-582941: A Novel Α7 Neuronal Nicotinic Receptor Agonist with Broad Spectrum Cognition-Enhancing Properties

Alpha 7 Nicotinic Acetylcholine Receptor and Its Effects on Alzheimer's Disease

Procognitive and Neuroprotective Activity of a Novel α7 Nicotinic Acetylcholine Receptor Agonist for Treatment of Neurodegenerative and Cognitive Disorders

Design and Synthesis of Novel Positive Allosteric Modulators of Α7 Nicotinic Acetylcholine Receptors with the Ability to Rescue Auditory Gating Deficit in Mice.

Discovery of Fused Heterocyclic Carboxamide Derivatives As Novel Α7-Nachr Agonists: Synthesis, Preliminary SAR and Biological Evaluation.

Virtual Screening for Alpha7 Nicotinic Acetylcholine Receptor for Treatment of Alzheimer's Disease.

Novel Positive Allosteric Modulators of the Human Α7 Nicotinic Acetylcholine Receptor

Synthesis and Biological Activities of Indolizine Derivatives As Alpha-7 Nachr Agonists

Pharmacological Characterization of JWX-A0108 As a Novel Type I Positive Allosteric Modulator of Α7 Nachr That Can Reverse Acoustic Gating Deficits in a Mouse Prepulse Inhibition Model

Natural Polyhydroxy Flavonoids, Curcuminoids, and Synthetic Curcumin Analogs as α7 nAChRs Positive Allosteric Modulators

A review of α7 nicotinic acetylcholine receptor and schizophrenia cognition